Else Nutrition Plans Canadian Market Relaunch in 2026
Rhea-AI Summary
Else Nutrition (OTC: BABYF) announced a planned relaunch of its Canadian business in early 2026 under a direct-to-retail model. The company said Canada previously exceeded CAD$1M revenue in 2023 but experienced declines in Q4 2024 and 1H 2025 due to out-of-stock and reduced marketing. Else terminated its distributor in July 2025, gained approval as a direct vendor with Canada's largest national retailer, and expects product back in stores in early 2026.
The company projects ~CAD$500,000 in Canadian revenue in the first year after relaunch and forecasts Canada reaching 10–15% of U.S. sales over time while expanding e-commerce and specialty channels.
AI-generated analysis. Not financial advice.
Positive
- Approved as a direct vendor with Canada's largest national retailer
- Projected CAD$500,000 initial-year Canadian revenue after relaunch
- Plan to expand Canadian e-commerce via Amazon and DTC platform
- Direct distribution model aimed at higher margins and commercial control
Negative
- Canadian revenue declined after 2023 despite surpassing CAD$1M
- Distributor relationship terminated in July 2025, causing channel disruption
- Projected initial-year revenue (~CAD$500k) is ~50% below 2023 Canadian revenue
Strategic Re-Entry Expected to Generate
Else initially entered the Canadian market in mid-2022 through a local distribution partner. The launch gained rapid traction, with Canadian revenues surpassing
During Q4 2024 and the first half of 2025, Canadian revenues declined due to temporary out-of-stock conditions and reduced marketing investment. In July 2025, the distributor relationship was terminated and the Company decided to transition to a direct distribution model, that offers higher margins and better commercial control.
As part of this strategy, Else initiated direct engagement with
In parallel, Else is advancing discussions to re-establish relationships with additional national retailers, onboard new retail partners, and appoint a local distributor to support specialty and independent retail channels. The Company also plans to expand its Canadian e-commerce presence through Amazon, its direct-to-consumer platform, and additional online marketplaces.
The Company expects Canadian operations to generate approximately
"We have always viewed
To delve deeper into Else Nutrition's offerings and its revolutionary approach to nutrition, visit www.elsenutrition.com
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at
Milan's Global Food Innovation Summit - #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
- During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
TSX
Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.